These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 11453370
1. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks. Barbelivien A, Nyman L, Haapalinna A, Sirviö J. Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370 [Abstract] [Full Text] [Related]
2. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. Tadano T, Satoh S, Satoh N, Kisara K, Arai Y, Kim SK, Kinemuchi H. J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477 [Abstract] [Full Text] [Related]
3. [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508]. Miklya I. Neuropsychopharmacol Hung; 2008 Mar; 10(1):15-22. PubMed ID: 18771016 [Abstract] [Full Text] [Related]
4. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action. He S, Grasing K. Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368 [Abstract] [Full Text] [Related]
5. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats. Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T. Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506 [Abstract] [Full Text] [Related]
6. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats. Kerecsen L, Bunag RD. J Pharmacol Exp Ther; 1989 Nov 27; 251(2):645-9. PubMed ID: 2509682 [Abstract] [Full Text] [Related]
7. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats. Cabanillas AM, Masini-Repiso AM, Costamagna ME, Pellizas C, Coleoni AH. J Endocrinol; 1994 Nov 27; 143(2):303-8. PubMed ID: 7829993 [Abstract] [Full Text] [Related]
8. Effects of selective monoamine oxidase (MAO) inhibitors on conditioned avoidance responses (CAR) of rats. Timár J, Knoll B, Gyarmati Z, Knoll J. Pol J Pharmacol Pharm; 1979 Nov 27; 31(4):251-60. PubMed ID: 523335 [Abstract] [Full Text] [Related]
9. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline). Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, Tariot PN, Sunderland T. J Neural Transm Suppl; 1998 Nov 27; 52():39-48. PubMed ID: 9564606 [Abstract] [Full Text] [Related]
10. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium. Lenzen S, Nahrstedt H, Panten U. Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov 27; 324(3):190-5. PubMed ID: 6419132 [Abstract] [Full Text] [Related]
11. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain. Olmos G, Gabilondo AM, Miralles A, Escriba PV, García-Sevilla JA. Br J Pharmacol; 1993 Mar 27; 108(3):597-603. PubMed ID: 8385528 [Abstract] [Full Text] [Related]
12. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. Lamensdorf I, Youdim MB, Finberg JP. J Neurochem; 1996 Oct 27; 67(4):1532-9. PubMed ID: 8858937 [Abstract] [Full Text] [Related]
13. The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats. Timár J, Knoll B. Arch Int Pharmacodyn Ther; 1986 Jan 27; 279(1):50-60. PubMed ID: 3083795 [Abstract] [Full Text] [Related]
14. Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl. Nowakowska E, Kus K, Chodera A, Rybakowski J. J Physiol Pharmacol; 2001 Dec 27; 52(4 Pt 2):863-73. PubMed ID: 11785779 [Abstract] [Full Text] [Related]
15. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L. Eur J Neurosci; 2006 Dec 27; 24(12):3532-40. PubMed ID: 17229101 [Abstract] [Full Text] [Related]
16. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity]. Severina IS, Klimova GI, Nersisian AA. Biokhimiia; 1981 Nov 27; 46(11):2043-55. PubMed ID: 6797482 [Abstract] [Full Text] [Related]
17. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man. Murphy DL, Lipper S, Slater S, Shiling D. Psychopharmacology (Berl); 1979 Apr 11; 62(2):129-32. PubMed ID: 111275 [Abstract] [Full Text] [Related]
18. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat. Malin DH, Moon WD, Goyarzu P, Barclay E, Magallanes N, Vela AJ, Negrete AP, Mathews H, Stephens B, Mills WR. Life Sci; 2013 Oct 06; 93(12-14):448-53. PubMed ID: 23988853 [Abstract] [Full Text] [Related]
19. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B]. Knoll J. Vopr Med Khim; 1997 Oct 06; 43(6):482-93. PubMed ID: 9503565 [Abstract] [Full Text] [Related]
20. The effects of selective and non-selective monoamine oxidase (MAO) inhibitors on conflict behavior in the rat. Commissaris RL, Humrich J, Johns J, Geere DG, Fontana DJ. Behav Pharmacol; 1995 Mar 06; 6(2):195-202. PubMed ID: 11224327 [Abstract] [Full Text] [Related] Page: [Next] [New Search]